ADA-话题@MedSci

#ADA#

386篇内容 | 2836人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1264683, encodeId=384a126468332, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Blood：ADAMTS13物种间高度保守的变构调节！, objectType=article, longId=159615, objectId=688d15961536, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=688d15961536, replyNumber=0, likeNumber=63, createdTime=2019-02-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=688d15961536, moduleTitle=Blood：ADAMTS13物种间高度保守的变构调节！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=688d15961536)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264682, encodeId=611d126468228, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Coherus宣布与AbbVie达成全球和解，确保其Adalimumab生物仿制药CHS-1420商业化的权利, objectType=article, longId=159211, objectId=6a41159211ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a41159211ca, replyNumber=0, likeNumber=49, createdTime=2019-01-31, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a41159211ca, moduleTitle=Coherus宣布与AbbVie达成全球和解，确保其Adalimumab生物仿制药CHS-1420商业化的权利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a41159211ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264681, encodeId=25881264681c3, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=欧盟委员会批准前列腺癌新药Erleada（apalutamide）：口服雄激素受体抑制剂, objectType=article, longId=159087, objectId=b24b15908e2c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b24b15908e2c, replyNumber=0, likeNumber=88, createdTime=2019-01-29, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b24b15908e2c, moduleTitle=欧盟委员会批准前列腺癌新药Erleada（apalutamide）：口服雄激素受体抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b24b15908e2c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264680, encodeId=c71d126468050, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=JAHA：高血钾症伴Brugada 表型患者的临床特征研究, objectType=article, longId=158863, objectId=f77a158863e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f77a158863e5, replyNumber=0, likeNumber=68, createdTime=2019-01-27, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f77a158863e5, moduleTitle=JAHA：高血钾症伴Brugada 表型患者的临床特征研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f77a158863e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264679, encodeId=e0cd12646e959, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=老年糖尿病管理建议（2019年ADA指南节选）, objectType=article, longId=158039, objectId=157e15803934, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=157e15803934, replyNumber=0, likeNumber=89, createdTime=2019-01-16, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=157e15803934, moduleTitle=老年糖尿病管理建议（2019年ADA指南节选）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=157e15803934)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264678, encodeId=5cd012646e824, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=AbbVie向美国FDA提交Upadacitinib治疗中重度类风湿性关节炎的新药申请, objectType=article, longId=156675, objectId=905a1566e5bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=905a1566e5bb, replyNumber=0, likeNumber=69, createdTime=2018-12-27, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=905a1566e5bb, moduleTitle=AbbVie向美国FDA提交Upadacitinib治疗中重度类风湿性关节炎的新药申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=905a1566e5bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264677, encodeId=035a12646e7df, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=重磅更新：2019年ADA糖尿病诊疗标准（中文版·中）, objectType=article, longId=156588, objectId=cf181565885f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf181565885f, replyNumber=0, likeNumber=69, createdTime=2018-12-26, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf181565885f, moduleTitle=重磅更新：2019年ADA糖尿病诊疗标准（中文版·中）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf181565885f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264676, encodeId=82bf12646e646, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=重磅更新：2019年ADA糖尿病诊疗标准（中文版·上）, objectType=article, longId=156587, objectId=dab215658e87, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dab215658e87, replyNumber=0, likeNumber=60, createdTime=2018-12-26, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dab215658e87, moduleTitle=重磅更新：2019年ADA糖尿病诊疗标准（中文版·上）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dab215658e87)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264675, encodeId=779d12646e5b8, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=重磅更新：2019年ADA糖尿病诊疗标准（中文版·下）, objectType=article, longId=156586, objectId=530a15658606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=530a15658606, replyNumber=0, likeNumber=76, createdTime=2018-12-26, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=530a15658606, moduleTitle=重磅更新：2019年ADA糖尿病诊疗标准（中文版·下）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=530a15658606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264674, encodeId=bf1b12646e43f, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2019版ADA糖尿病诊疗标准发布更新要点已为你梳理好了！, objectType=article, longId=156289, objectId=20d41562897e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20d41562897e, replyNumber=0, likeNumber=66, createdTime=2018-12-22, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20d41562897e, moduleTitle=2019版ADA糖尿病诊疗标准发布更新要点已为你梳理好了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20d41562897e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264673, encodeId=9a9f12646e337, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=JACC：Brugada 综合征患者常同时存在结构和电生理的异常, objectType=article, longId=154726, objectId=f804154e2633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f804154e2633, replyNumber=0, likeNumber=86, createdTime=2018-12-01, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f804154e2633, moduleTitle=JACC：Brugada 综合征患者常同时存在结构和电生理的异常, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f804154e2633)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264672, encodeId=57aa12646e257, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2018 ADA立场声明：青年起病的2型糖尿病的评估和管理, objectType=article, longId=153999, objectId=0b0415399909, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b0415399909, replyNumber=0, likeNumber=27, createdTime=2018-11-22, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b0415399909, moduleTitle=2018 ADA立场声明：青年起病的2型糖尿病的评估和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b0415399909)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264671, encodeId=fdf412646e124, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2018 ADA/EASD共识：2型糖尿病患者高血糖的管理, objectType=article, longId=150702, objectId=7a2b150e027e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a2b150e027e, replyNumber=0, likeNumber=23, createdTime=2018-10-11, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a2b150e027e, moduleTitle=2018 ADA/EASD共识：2型糖尿病患者高血糖的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a2b150e027e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264670, encodeId=e24b12646e0a8, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2018 ADA循证临床实践指南：龋齿性病变的非恢复性治疗, objectType=article, longId=150340, objectId=938b15034055, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=938b15034055, replyNumber=0, likeNumber=30, createdTime=2018-10-05, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=938b15034055, moduleTitle=2018 ADA循证临床实践指南：龋齿性病变的非恢复性治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=938b15034055)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264669, encodeId=b4ad126466913, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=上海医疗机构率先成功为小年龄儿童完成Wada试验, objectType=article, longId=149836, objectId=b4e1149836bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4e1149836bc, replyNumber=0, likeNumber=52, createdTime=2018-09-29, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4e1149836bc, moduleTitle=上海医疗机构率先成功为小年龄儿童完成Wada试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4e1149836bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264668, encodeId=5408126466866, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Brugada综合征，千万别搞错！, objectType=article, longId=149086, objectId=0a8c149086db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a8c149086db, replyNumber=0, likeNumber=0, createdTime=2018-09-20, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a8c149086db, moduleTitle=Brugada综合征，千万别搞错！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a8c149086db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264667, encodeId=8a63126466e80, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=J Endod：Twisted File Adaptive和Navigator EVO器械在不同运动模式下根管偏移、定心能力以及循环疲劳比较, objectType=article, longId=147077, objectId=d1c714e077dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1c714e077dc, replyNumber=0, likeNumber=68, createdTime=2018-08-22, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1c714e077dc, moduleTitle=J Endod：Twisted File Adaptive和Navigator EVO器械在不同运动模式下根管偏移、定心能力以及循环疲劳比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1c714e077dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264666, encodeId=16bb126466645, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2018 ADA立场声明：儿童和青少年1型糖尿病, objectType=article, longId=146669, objectId=0b03146669d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b03146669d9, replyNumber=0, likeNumber=34, createdTime=2018-08-16, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b03146669d9, moduleTitle=2018 ADA立场声明：儿童和青少年1型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b03146669d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264665, encodeId=79711264665ac, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=美国FDA批准Omadacycline抗生素上市, objectType=article, longId=146516, objectId=1f8a146516ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f8a146516ba, replyNumber=0, likeNumber=76, createdTime=2018-08-14, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f8a146516ba, moduleTitle=美国FDA批准Omadacycline抗生素上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f8a146516ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264664, encodeId=3f7b1264664e9, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=J Cell Physiol：化的脂肪来源的干细胞共培养物用于RADA16-I中的骨再生, objectType=article, longId=146134, objectId=0af41461341f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0af41461341f, replyNumber=0, likeNumber=57, createdTime=2018-08-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0af41461341f, moduleTitle=J Cell Physiol：化的脂肪来源的干细胞共培养物用于RADA16-I中的骨再生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0af41461341f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ADA

2020-05-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Blood：ADAMTS13物种间高度保守的变构调节！

2019-02-09

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Coherus宣布与AbbVie达成全球和解，确保其Adalimumab生物仿制药CHS-1420商业化的权利

2019-01-31

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

欧盟委员会批准前列腺癌新药Erleada（apalutamide）：口服雄激素受体抑制剂

2019-01-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

JAHA：高血钾症伴Brugada 表型患者的临床特征研究

2019-01-27

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

老年糖尿病管理建议（2019年ADA指南节选）

2019-01-16

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

AbbVie向美国FDA提交Upadacitinib治疗中重度类风湿性关节炎的新药申请

2018-12-27

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

重磅更新：2019年ADA糖尿病诊疗标准（中文版·中）

2018-12-26

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

重磅更新：2019年ADA糖尿病诊疗标准（中文版·上）

2018-12-26

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

重磅更新：2019年ADA糖尿病诊疗标准（中文版·下）

2018-12-26

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2019版ADA糖尿病诊疗标准发布更新要点已为你梳理好了！

2018-12-22

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

JACC：Brugada 综合征患者常同时存在结构和电生理的异常

2018-12-01

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2018 ADA立场声明：青年起病的2型糖尿病的评估和管理

2018-11-22

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2018 ADA/EASD共识：2型糖尿病患者高血糖的管理

2018-10-11

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2018 ADA循证临床实践指南：龋齿性病变的非恢复性治疗

2018-10-05

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

上海医疗机构率先成功为小年龄儿童完成Wada试验

2018-09-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Brugada综合征，千万别搞错！

2018-09-20

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

J Endod：Twisted File Adaptive和Navigator EVO器械在不同运动模式下根管偏移、定心能力以及循环疲劳比较

2018-08-22

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2018 ADA立场声明：儿童和青少年1型糖尿病

2018-08-16

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

美国FDA批准Omadacycline抗生素上市

2018-08-14

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

J Cell Physiol：化的脂肪来源的干细胞共培养物用于RADA16-I中的骨再生

2018-08-09

科室
- - 订阅+
  - 更多科室
工具
服务